DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

480.09 0.01 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

REGN $480.09 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $479.16
Previous Close $480.08
Daily Range $475.02 - $486.00
52-Week Range $269.50 - $495.50
Market Cap $49.3B
P/E Ratio 156.38
Dividend (Yield) $0.00 (0.0%)
Volume 909,083
Average Daily Volume 889,390
Current FY EPS $7.79




Drug Makers

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website:

News & Commentary Rss Feed

The 3 Best Stocks for Investing in Cholesterol Drugs

An aging population and rising prevalence of heart disease suggest that investing in the next generation of cholesterol drugs could prove to be profitable.

Regeneron Bounces Higher Off Support

3 Potential Blockbuster Drugs That Could Be Approved Before Year's End

Our experts weigh in on some drug candidates with huge potential.

10 Largest Companies by Market Cap in Biotech

The bigger they are, the harder they climb? How the biggest biotechs are booming.

Jim Cramer -- If You're Not in Biotech for the Long Haul, Hit the Road

Nasdaq 100 Movers: VIAB, REGN

Following Gilead Sciences, Inc., Which Biotech Will Pay a Dividend Next?

Our experts weigh in.

Biotech Bubble Valuations From Sam Islay

Biotech Stock Roundup: Horizon to Buy Hyperion, Conatus Up on Liver Disease Data - Analyst Blog

Stock Market News for April 01, 2015 - Market News

See More REGN News...

REGN's Top Competitors

REGN $480.09 (0.00%)
Current stock: REGN
AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
BIIB $401.71 (-6.64%)
Current stock: BIIB